We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis’ Troubled Lincoln Plant to Stay Sidelined Until 2013: CEO
Novartis’ Troubled Lincoln Plant to Stay Sidelined Until 2013: CEO
November 5, 2012
Slow remediation of GMP problems at Novartis’ Lincoln, Neb., OTC drug plant has dashed hopes for a pre-2013 return to production, company officials say.